Drugs / GPO Tri Fluvac vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04548518 Comparator | Aug 2020 → Jun 2023 | influenza | Mahidol University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GPO Tri Fluvac vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04548518 ↗ |
| Modality | Vaccine | “seasonal trivalent inactivated split virion influenza vaccine” NCT04548518 ↗ |
| Route | Intramuscular | “to be administered by intramuscular (IM) injection” NCT04548518 ↗ |